GentiBio
Carlos Frias is a Senior Associate Scientist with a background in in-vivo pharmacology and a strong foundation in biology. With experience in urine collection and weighing various animal species, Carlos has worked with leading pharmaceutical companies such as Sanofi, GentiBio, Acceleron Pharma, and Takeda Oncology. Starting as an Animal Care Technician, Carlos has steadily progressed in their career, showcasing expertise and dedication in the field of science and research.
This person is not in the org chart
GentiBio
GentiBio, Inc., is an early stage biotherapeutics company co-founded by pioneers in Treg biology and synthetic immunology to develop engineered regulatory T cells (EngTregs) programmed to treat autoimmune, alloimmune, autoinflammatory and allergic diseases. GentiBio's proprietary autologous and allogeneic EngTregs platform integrates key complimentary technologies needed to successfully restore immune tolerance and overcome major limitations in existing regulatory T-cell therapeutics. GentiBio is at the forefront of leveraging a unique therapeutic modality that can be used to address the fundamental cause of many diseases that result from overshooting and/or malfunctioning of the immune system.